Outbreaks of vaccine-preventable diseases are increasing at a time when funding for immunisation programmes is being cut.

Life sciences drive innovation in medicine, food and sustainable production, adding nearly €1.5 trillion in value to the EU economy and supporting 29 million jobs across the European Union.

Croatia, Estonia, France, Germany, Lithuania, Slovenia and Spain produced an information note highlighting the loss of confidence in science and health authorities, representing a major challenge for democracies.

New respiratory syncytial virus (RSV) vaccines have been approved in the USA for the prevention of RSV-associated lower respiratory tract disease in adults aged 60 years and older.

This group will lead the development of a Call to Action to advocate for better access to treatments, in particular COVID- 19.

Agreement’s adoption follows three years of intensive negotiation launched due to gaps and inequities identified in national and global COVID-19 response.

Celebrated the XIX European Patients’ Rights Day at the EU Parliament

The 2025 edition provides the most comprehensive and up-to-date analysis of the nursing workforce.